Search Results 71-80 of 16652 for Fluvastatin

  1. Rifaximin (oral route) - Side effects & dosage - Mayo Clinic

    Rifaximin is used to treat traveler's diarrhea that is caused by a bacteria called Escherichia coli. It is also used to prevent hepatic encephalopathy, which is ...

  2. Givinostat (oral route) - Side effects & dosage - Mayo Clinic

    Givinostat is used to treat Duchenne muscular dystrophy (DMD). DMD is a rare, inherited muscle disease that is caused by the absence of a protein called ...

  3. Dolutegravir and rilpivirine (oral route) - Mayo Clinic

    This medicine will not cure HIV infection or AIDS. It works by lowering the amount of HIV in the blood and it will also help your immune system. This may help ...

  4. Rivastigmine (oral route) - Side effects & dosage - Mayo Clinic

    This medicine is available only with your doctor's prescription. This product is available in the following dosage forms: Capsule. Back to top ...

  5. Flutemetamol f 18 (intravenous route) - Side effects & uses - Mayo Clinic

    Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you ...

  7. Efavirenz (oral route) - Side effects & dosage - Mayo Clinic

    This medicine will not cure HIV infection or AIDS. It works by lowering the amount of HIV in the blood and helps the immune system. This may help delay some of ...

  8. Felodipine (oral route) - Mayo Clinic

    This can damage the blood vessels of the brain, heart, and kidneys, resulting in a stroke, heart failure, or kidney failure. High blood pressure may also ...

  9. Fitusiran (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Fitusiran injection is used to prevent or decrease the frequency of bleeding episodes in patients with hemophilia A or B with or without factor VIII or IX ...

  10. New and novel treatments for hyperlipidemia - Mayo Clinic

    Clinical outcome trials study the use of human monoclonal antibodies to target biochemical pathways that impact LDL receptor availability and monoclonal ...